Ocular Therapeutix Eye Drug Meets Goal in Late-Stage StudyOcular Therapeutix Eye Drug Meets Goal in Late-Stage Study

Ocular Therapeutix Inc said its lead eye drug reduced pain and inflammation in patients following cataract surgery in a late-stage trial. Reuters Health Information
Source: Medscape Ophthalmology Headlines - Category: Opthalmology Tags: Ophthalmology News Source Type: news